Viking Therapeutics, Inc. logo VKTX - Viking Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 1
BUY 22
HOLD 1
SELL 0
STRONG
SELL 0
| PRICE TARGET: $98.67 DETAILS
HIGH: $101.00
LOW: $95.00
MEDIAN: $100.00
CONSENSUS: $98.67
UPSIDE: 219.42%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 9.33
Quick Ratio 9.33
Solvency Ratio -4.685
Cash Ratio 2.16

Valuation Ratios

Ratio Value
Price/Earnings
-11.02
Peers avg: 22.6
PEG Ratio -0.05
Forward PEG -0.05
Price/Book 6.20
Price/Sales 0.00
Price/FCF -14.22
Price/Op Cash Flow -14.22

Debt Ratios

Ratio Value
Debt/Assets 0.0002
Debt/Equity 0.0002
Debt/Capital 0.0002
Long-Term Debt/Capital 0.0000
Financial Leverage 1.12

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -3.635
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 100.0%

Coverage Ratios

Ratio Value
Debt Service Coverage -7023.96
Interest Coverage -7023.9643
Short-Term Operating Cash Flow Coverage 0.00
Operating Cash Flow Coverage -2034.20
Capital Expenditure Coverage 0.00
Dividend + Capital Expenditure Coverage 0.00

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -3.192
Debt/Share 0.0017
Cash/Share 6.26
Book Value/Share 5.67
Tangible BV/Share 5.67
Equity/Share 5.67
Operating Cash Flow/Share -2.474
Capital Expenditure/Share 0.000
FCF/Share -2.474

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.914
Price/Fair Value 6.20
Debt/Market Cap 0.0000
Effective Tax Rate 0.0%
Enterprise Value Multiple -9.66